State of New Jersey Common Pension Fund D lessened its holdings in shares of DaVita Inc. (NYSE:DVA – Free Report) by 11.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 17,333 shares of the company’s stock after selling 2,196 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in DaVita were worth $2,592,000 at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in the business. Strategic Financial Concepts LLC purchased a new position in shares of DaVita during the 4th quarter worth $9,371,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in shares of DaVita during the 4th quarter worth $597,000. Summit Trail Advisors LLC lifted its stake in shares of DaVita by 9.0% during the 4th quarter. Summit Trail Advisors LLC now owns 25,416 shares of the company’s stock worth $3,801,000 after purchasing an additional 2,107 shares during the period. Wingate Wealth Advisors Inc. purchased a new position in shares of DaVita during the 4th quarter worth $82,000. Finally, Empowered Funds LLC lifted its stake in shares of DaVita by 856.4% during the 4th quarter. Empowered Funds LLC now owns 55,698 shares of the company’s stock worth $8,330,000 after purchasing an additional 49,874 shares during the period. Hedge funds and other institutional investors own 90.12% of the company’s stock.
Analyst Upgrades and Downgrades
Separately, Barclays increased their price target on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $162.80.
DaVita Trading Down 5.8 %
DVA stock opened at $145.99 on Friday. The company has a market cap of $11.68 billion, a price-to-earnings ratio of 13.59, a PEG ratio of 1.01 and a beta of 0.94. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The business has a fifty day simple moving average of $161.24 and a 200-day simple moving average of $157.81. DaVita Inc. has a 52 week low of $119.42 and a 52 week high of $179.60.
DaVita (NYSE:DVA – Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, equities research analysts expect that DaVita Inc. will post 10.72 EPS for the current year.
About DaVita
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Stories
- Five stocks we like better than DaVita
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA – Free Report).
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.